[1] Davidson KC, Mason EA, Pera MF. The pluripotent state in mouse and human. Development. 2015;142(18):3090-3099.[2] Takahashi K, Tanabe K, Ohnuki M,et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861-872.[3] Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19(10):971-874.[4] Prowse AB, Doran MR, Cooper-White JJ, et al. Long term culture of human embryonic stem cells on recombinant vitronectin in ascorbate free media. Biomaterials. 2010;31(32): 8281-8288.[5] Li L, Wang S, Jezierski A, et al. A unique interplay between Rap1 and E-cadherin in the endocytic pathway regulates self-renewal of human embryonic stem cells. Stem Cells. 2010;28(2):247-257.[6] Miyazaki T, Futaki S, Suemori H, et al. Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat Commun. 2012;3:1236.[7] Rodin S, Antonsson L, Niaudet C, et al. Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat Commun. 2014;5:3195.[8] Shibata S, Hayashi R, Okubo T, et al. Selective Laminin-Directed Differentiation of Human Induced Pluripotent Stem Cells into Distinct Ocular Lineages. Cell Rep. 2018;25(6):1668-1679.[9] Klim JR, Li L, Wrighton PJ, et al. A defined glycosaminoglycan- binding substratum for human pluripotent stem cells. Nat Methods. 2010;7(12):989-994.[10] Melkoumian Z, Weber JL, Weber DM, et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol. 2010;28(6):606-610.[11] Brafman DA, Chang CW, Fernandez A, et al. Long-term human pluripotent stem cell self-renewal on synthetic polymer surfaces. Biomaterials. 2010;31(34):9135-9144.[12] Lock LT, Tzanakakis ES. Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng. 2007;13(7):1399-1412.[13] Chen AK, Chen X, Choo AB, et al. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res. 2011;7(2):97-111.[14] Sart S, Schneider YJ, Li Y, et al. Stem cell bioprocess engineering towards cGMP production and clinical applications. Cytotechnology. 2014;66(5):709-722.[15] Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix: a dynamic microenvironment for stem cell niche. Biochim Biophys Acta. 2014;1840(8):2506-2519.[16] Chang CW, Hwang Y, Brafman D, et al. Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells. Biomaterials. 2013;34(4):912-921.[17] Oh SK, Chen AK, Mok Y, et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009;2(3):219-230.[18] Storm MP, Orchard CB, Bone HK, et al. Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells. Biotechnol Bioeng. 2010;107(4):683-695.[19] Rodrigues CA, Fernandes TG, Diogo MM, et al. Stem cell cultivation in bioreactors.Biotechnol Adv. 2011;29(6):815-829.[20] Jenkins MJ, Farid SS. Human pluripotent stem cell-derived products: advances towards robust, scalable and cost-effective manufacturing strategies. Biotechnol J. 2015;10(1):83-95.[21] Bardy J, Chen AK, Lim YM, et al. Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng Part C Methods. 2013;19(2):166-180.[22] Hundt B, Best C, Schlawin N, et al. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale. Vaccine. 2007;25(20):3987-3995.[23] Liu N, Li Y, Yang ST. Expansion of embryonic stem cells in suspension and fibrous bed bioreactors. J Biotechnol. 2014; 178:54-64.[24] Zweigerdt R, Olmer R, Singh H, et al. Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc. 2011;6(5):689-700.[25] Chen KG, Mallon BS, McKay RD, et al. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell. 2014;14(1):13-26.[26] Gerecht-Nir S, Cohen S, Itskovitz-Eldor J. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng. 2004; 86(5):493-502.[27] Amit M, Chebath J, Margulets V, et al. Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev. 2010;6(2):248-259.[28] Singh H, Mok P, Balakrishnan T, et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res. 2010;4(3):165-179.[29] Kempf H, Olmer R, Kropp C, et al. Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports. 2014;3(6): 1132-1146.[30] Silva MM, Rodrigues AF, Correia C, et al. Robust Expansion of Human Pluripotent Stem Cells: Integration of Bioprocess Design With Transcriptomic and Metabolomic Characterization. Stem Cells Transl Med. 2015;4(7):731-742.[31] Serra M, Brito C, Sousa MF, et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol. 2010;148(4):208-215.[32] Kinney MA, Sargent CY, McDevitt TC. The multiparametric effects of hydrodynamic environments on stem cell culture. Tissue Eng Part B Rev. 2011;17(4):249-262.[33] Liu N, Zang R, Yang ST, et al. Stem cell engineering in bioreactors for large-scale bioprocessing. Engineering in Life Sciences. 2014; 14(1): 4-15.[34] Olmer R, Lange A, Selzer S, et al. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods. 2012;18(10):772-784.[35] Teo A, Mantalaris A, Lim M, et al. Influence of culture pH on proliferation and cardiac differentiation of murine embryonic stem cells. Biochemical Engineering Journal. 2014; 90(15): 8-15.[36] Shafa M, Krawetz R, Zhang Y, et al. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC Cell Biol. 2011;12:53.[37] Gareau T, Lara GG, Shepherd RD, et al. Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med. 2014;8(4):268-278.[38] Leung HW, Chen A, Choo AB, et al. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods. 2011; 17(2):165-172.[39] Wan X, Ball S, Willenbrock F, et al. Perfused Three-dimensional Organotypic Culture of Human Cancer Cells for Therapeutic Evaluation. Sci Rep. 2017;7(1):9408.[40] Côme J, Nissan X, Aubry L, et al. Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Tissue Eng Part C Methods. 2008;14(4):289-298.[41] Kurosawa H. Methods for inducing embryoid body formation: in vitro differentiation system of embryonic stem cells. J Biosci Bioeng. 2007;103(5):389-398.[42] Carpenedo RL, Sargent CY, McDevitt TC. Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation. Stem Cells. 2007;25(9): 2224-2234.[43] Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol. 2007;25(6):681-686.[44] Choi YY, Chung BG, Lee DH, et al. Controlled-size embryoid body formation in concave microwell arrays. Biomaterials. 2010;31(15):4296-4303.[45] Bauwens CL, Toms D, Ungrin M. Aggregate Size Optimization in Microwells for Suspension-based Cardiac Differentiation of Human Pluripotent Stem Cells. J Vis Exp. 2016;(115):e54308.[46] Abbasalizadeh S, Larijani MR, Samadian A, et al. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods. 2012;18(11):831-851.[47] Sargent CY, Berguig GY, Kinney MA, et al. Hydrodynamic modulation of embryonic stem cell differentiation by rotary orbital suspension culture. Biotechnol Bioeng. 2010;105(3): 611-626.[48] Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A. 2009;15(8):2051-2063.[49] Xu RH, Peck RM, Li DS, et al. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat Methods. 2005;2(3):185-190.[50] Lee MO, Jeon H, Son MY, et al. Clump-passaging-based efficient 3D culture of human pluripotent stem cells under chemically defined conditions. Biochem Biophys Res Commun. 2017;493(1):723-730.[51] Otsuji TG, Bin J, Yoshimura A, et al. A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production. Stem Cell Reports. 2014;2(5): 734-745.[52] Nath SC, Tokura T, Kim MH, et al. Botulinum hemagglutinin-mediated in situ break-up of human induced pluripotent stem cell aggregates for high-density suspension culture. Biotechnol Bioeng. 2018;115(4):910-920.[53] Chen X, Prowse AB, Jia Z, et al. Thermoresponsive worms for expansion and release of human embryonic stem cells. Biomacromolecules. 2014;15(3):844-855.[54] Badenes SM, Fernandes TG, Cordeiro CS, et al. Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems. PLoS One. 2016;11(3):e0151264.[55] Fernandes AM, Marinho PA, Sartore RC, et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz J Med Biol Res. 2009;42(6): 515-522.[56] Heng BC, Li J, Chen AK, et al. Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev. 2012;21(10):1701-1715.[57] Fan Y, Hsiung M, Cheng C, et al. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A. 2014;20(3-4):588-599.[58] Fan Y, Zhang F, Tzanakakis ES, et al. Engineering Xeno-Free Microcarriers with Recombinant Vitronectin, Albumin and UV Irradiation for Human Pluripotent Stem Cell Bioprocessing. ACS Biomater Sci Eng. 2017;3(8):1510-1518.[59] Lam AT, Li J, Chen AK, et al. Cationic surface charge combined with either vitronectin or laminin dictates the evolution of human embryonic stem cells/microcarrier aggregates and cell growth in agitated cultures. Stem Cells Dev. 2014;23(14):1688-1703.[60] Lam AT, Li J, Chen AK, et al. Improved Human Pluripotent Stem Cell Attachment and Spreading on Xeno-Free Laminin-521-Coated Microcarriers Results in Efficient Growth in Agitated Cultures. Biores Open Access. 2015;4(1):242-257.[61] Villa-Diaz LG, Nandivada H, Ding J, et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol. 2010;28(6):581-583.[62] Badenes SM, Fernandes TG, Rodrigues CA, et al. Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers. Methods Mol Biol. 2015;1283:23-29.[63] Badenes SM, Fernandes TG, Miranda CC, et al. Long-term expansion of human induced pluripotent stem cells in amicrocarrier-based dynamic system. Journal of Chemical Technology and Biotechnology. 2017; 92(3): 482-493.[64] Chen AK, Reuveny S, Oh SK. Application of human mesenchymal and pluripotent stem cell microcarrier cultures in cellular therapy: achievements and future direction. Biotechnol Adv. 2013;31(7):1032-1046.[65] Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm. 2006;323(1-2):34-42.[66] Serra M, Correia C, Malpique R, et al. Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One. 2011;6(8):e23212.[67] Siti-Ismail N, Bishop AE, Polak JM, et al. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials. 2008;29(29): 3946-3952.[68] Wilson JL, McDevitt TC. Stem cell microencapsulation for phenotypic control, bioprocessing, and transplantation. Biotechnol Bioeng. 2013;110(3):667-682.[69] Wilson JL, Najia MA, Saeed R, et al. Alginate encapsulation parameters influence the differentiation of microencapsulated embryonic stem cell aggregates. Biotechnol Bioeng. 2014; 111(3):618-631.[70] Jing D, Parikh A, Tzanakakis ES. Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant. 2010;19(11):1397-1412.[71] Ikeda K, Nagata S, Okitsu T, et al. Cell fiber-based three-dimensional culture system for highly efficient expansion of human induced pluripotent stem cells. Sci Rep. 2017;7(1):2850.[72] Dang SM, Gerecht-Nir S, Chen J, et al. Controlled, scalable embryonic stem cell differentiation culture. Stem Cells. 2004; 22(3):275-282.[73] Gerecht S, Burdick JA, Ferreira LS, et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A. 2007;104(27):11298-11303.[74] Li Q, Wang Q, Wang O, et al. A simple and scalable hydrogel-based system for culturing protein-producing cells. PLoS One. 2018;13(1):e0190364.[75] Lei Y, Jeong D, Xiao J, et al. Developing Defined and Scalable 3D Culture Systems for Culturing Human Pluripotent Stem Cells at High Densities. Cell Mol Bioeng. 2014;7(2): 172-183.[76] Lin H, Li Q, Lei Y. Three-dimensional tissues using human pluripotent stem cell spheroids as biofabrication building blocks. Biofabrication. 2017;9(2):025007.[77] Lei Y, Schaffer DV. A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation. Proc Natl Acad Sci U S A. 2013;110(52): E5039-5048. |